International Rare Brain Tumor Registry
Sponsor: Children's National Research Institute · NCT05697874 on ClinicalTrials.gov ↗
Conditions studied
Where it's running10 sites
- Recruiting now
Children's Hospital Los Angeles
Los Angeles, California 90027
- Nathan Robison, MD(contact)323-361-4624[email protected]
- Eliana Romero(contact)323-361-8957[email protected]
- Nathan Robison, MD(principal investigator)
- Recruiting now
University of California San Francisco
San Francisco, California 94158
- Marie Jaeger-Krause, MD(contact)4154763831[email protected]
- Cammy Britts(contact)(650)-796-8115[email protected]
- Marie Jaeger-Krause, MD(principal investigator)
- Recruiting now
Children's National Hospital
Washington D.C., District of Columbia 20010
- Adriana Fonseca, MD(contact)202-476-3899[email protected]
- Hope Lovell(contact)202-476-3898[email protected]
- Adriana Fonseca, MD(principal investigator)
- Roger J. Packer, MD(sub investigator)
- Recruiting now
Ann & Robert H. Lurie Children's Hospital of Chicago
Chicago, Illinois 60611
- Miriam Bornhorst, MD(contact)2024762140[email protected]
- Kelly Bruno(contact)[email protected]
- Miriam Bornhorst, MD(principal investigator)
- Recruiting now
Akron Children's Hospital
Akron, Ohio 44308
- Erin Wright, MD(contact)3305438580[email protected]
- Emily Blue(contact)[email protected]
- Erin Wright, MD(principal investigator)
- Recruiting now
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio 45229-3026
- Scott Raskin, DO(contact)(513) 636-4200[email protected]
- Cecilia Grizzell(contact)[email protected]
- Scott Raskin, DO(principal investigator)
4 international sites
- Recruiting now
Rambam Health Care Campus
Haifa, Israel 3525409
- Liat Oren, MD(contact)04-7774718[email protected]
- Hadar Aktin Moustcki(contact)[email protected]
- Liat Oren, MD(principal investigator)
- Recruiting now
Schneider Children's Medical Center- CLALIT Health Services
Petah Tikva, Israel 4920235
- Helen Toledano, MD(contact)054-8885563[email protected]
- Tehila Tannin(contact)[email protected]
- Helen Toledano, MD(principal investigator)
- Recruiting now
Dana-Dwek Children's Hospital- Tel Aviv Medical Center
Tel Aviv, Israel 6423906
- Yair Peled, MD(contact)+97236974444[email protected]
- Ziva Rosenthal Galili(contact)[email protected]
- Yair Peled, MD(principal investigator)
- Recruiting now
The Sheba Medical Center
Tel Litwinsky, Israel 52621
- Michal Oren, MD, PhD(contact)972-523-595718[email protected]
- Orit Savyon(contact)[email protected]
- Michal Oren, MD, PhD(principal investigator)
See the official eligibility language
Shown exactly as written on ClinicalTrials.gov. Your oncologist is the right person to judge whether it fits your situation.
Inclusion Criteria: * Patients with a known or suspected CNS Sarcoma. * Patients with a known or suspected BCOR-altered brain tumor * Patients with a known or suspected Astroblastoma/NM-1 altered brain tumor * Patients with known or suspected histologically ambiguous/unclassifiable brain tumor * Patients with a known or suspected rare brain tumor. * Signed informed consent by patient/ parent or guardian (assent where applicable) to participate in the study. Exclusion Criteria: * The patient has an extra-CNS primary tumor. * The patient is older than 46 years of age at diagnosis. * The patient or family is not willing to participate or does not sign informed consent.
Updated 2026-03-31 on ClinicalTrials.gov. Always confirm current details with the study team or your oncologist.